Wuhan Zonke Optoelectronic Technology Co., Ltd.
Nubake
Niu Baik Therapy Device
The nemesis of psoriasis, psoriatic arthritis, and vitiligo.
The Niubaike 308/365 nm laser therapy device is a cutting-edge laser‑based instrument developed by the Chinese Academy of Sciences. It features a national invention patent for aluminum gallium nitride crystal light‑emitting technology, offering a pure light source, low power consumption, comprehensive treatment coverage with no blind spots, and exceptional safety and reliability. This design enhances the precision and targeted delivery of therapy; its light‑radiation intensity is several times that of conventional ultraviolet light, enabling rapid penetration to the lesion and improving patient tolerance. It is a high‑tech medical device indicated for the treatment of vitiligo, scleroderma, psoriasis, and erythematous skin disorders.
Product Highlights
Patented Semiconductor Crystal Light Source Technology
Adopts proprietary patented semiconductor crystal light source, delivering pure spectrum and high-intensity stable irradiation output.
Continuous Irradiation Optimizes Skin Energy Absorption
Continuous uniform irradiation improves skin tolerance to light therapy, greatly boosting the absorption efficiency of light energy by lesion tissues.
Fast Depigmentation Correction with Instant Visible Improvement
Fast-acting vitiligo repigmentation treatment, with obvious therapeutic effects observable right after treatment sessions.
Synergistic Therapy with 365nm UVA1 Wavelength
When combined with 365nm long-wave UVA1 light and matched with auxiliary treatment regimens, it effectively accelerates melanocyte proliferation in dermis and hair follicles.
Working Mechanisms
308nm Excimer Laser
Precision-targeted 308nm monochromatic UV acts directly on vitiligo lesional dermis. It eliminates lesion-infiltrated autoimmune T cells to halt melanocyte damage, meanwhile activating residual melanocytes and boosting vitamin D3 secretion to drive melanin regeneration. Safe non-surgical alternative for children and pregnant patients unsuitable for transplantation or drug therapy.
Upgradable 308/365nm Dual System
365nm UVA1 long-wave UV features superior deep skin penetration. It modulates fibroblast MMP expression to resolve abnormal collagen deposition and suppress chronic inflammation, providing targeted treatment for scleroderma, keloids, eczema and intractable inflammatory dermatoses. UVA1 phototherapy has been widely adopted in dermatology clinics since 1992.
Application Range
Vitiligo, Psoriasis, Scleroderma
Polymorphic Light Eruption, Chronic Actinic Dermatitis, Solar Urticaria
Atopic Dermatitis & Eczema
Pretibial Myxedema
Lichen Planus, Systemic Lupus Erythematosus
Callous Swelling, Palmoplantar Dyshidrotic Eczema
Allergic Dermatitis & Other Immune-Mediated Skin Disorders
Real Cases
Before treatment
Next treatment
Two treatments
Honors and Qualifications
Flagship Clients
Related products